- Home
- USFD vs RPRX Comparison
USFD vs RPRX Comparison
Compare USFD & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USFD
- RPRX
- Stock Information
- Founded
- USFD 2007
- RPRX 1996
- Country
- USFD United States
- RPRX United States
- Employees
- USFD N/A
- RPRX N/A
- Industry
- USFD Food Distributors
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- USFD Consumer Discretionary
- RPRX Health Care
- Exchange
- USFD Nasdaq
- RPRX Nasdaq
- Market Cap
- USFD 16.9B
- RPRX 16.2B
- IPO Year
- USFD 2016
- RPRX 2020
- Fundamental
- Price
- USFD $73.48
- RPRX $38.50
- Analyst Decision
- USFD Strong Buy
- RPRX Strong Buy
- Analyst Count
- USFD 11
- RPRX 3
- Target Price
- USFD $88.36
- RPRX $46.00
- AVG Volume (30 Days)
- USFD 1.9M
- RPRX 3.4M
- Earning Date
- USFD 11-06-2025
- RPRX 11-05-2025
- Dividend Yield
- USFD N/A
- RPRX 2.28%
- EPS Growth
- USFD 2.09
- RPRX N/A
- EPS
- USFD 2.38
- RPRX 1.75
- Revenue
- USFD $39,115,000,000.00
- RPRX $2,349,844,000.00
- Revenue This Year
- USFD $6.54
- RPRX $36.16
- Revenue Next Year
- USFD $6.01
- RPRX $2.04
- P/E Ratio
- USFD $30.82
- RPRX $22.01
- Revenue Growth
- USFD 4.80
- RPRX 3.70
- 52 Week Low
- USFD $57.36
- RPRX $24.05
- 52 Week High
- USFD $85.11
- RPRX $41.24
- Technical
- Relative Strength Index (RSI)
- USFD 43.54
- RPRX 56.61
- Support Level
- USFD $72.20
- RPRX $36.03
- Resistance Level
- USFD $74.28
- RPRX $41.24
- Average True Range (ATR)
- USFD 1.42
- RPRX 1.17
- MACD
- USFD -0.09
- RPRX 0.28
- Stochastic Oscillator
- USFD 35.26
- RPRX 48.17
About USFD US Foods Holding Corp.
US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.